Ozempic and Wegovy aren’t affecting PepsiCo’s business much — but this trend is

The new class of weight-loss drugs like Ozempic and Wegovy are having a negligible impact on PepsiCo Inc.’s snacks and beverages business, but the trend of healthier eating is causing customers to seek smaller packages and to consume less sugar and salt.

That allows for greater convenience, variety and portion control, he said, and the company is continuing its push toward healthier snacking and beverage options, including zero-sugar beverages and nutritious convenience foods with lower sodium content. Walmart’s U.S. chief executive, John Furner, told Bloomberg in an interview that the company can track which of its customers are taking the drugs and can see that they are causing a “slight pullback in overall basket” and “less units, slightly less calories.”

Read now: As Ozempic/Wegovy frenzy continues, Morgan Stanley lifts forecasts for weight-loss drugs to $77 billion

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

How Ozempic and Wegovy turned Novo Nordisk into a $400 billion companyHow Ozempic and Wegovy turned Novo Nordisk into a $400 billion company
출처: nbcsandiego - 🏆 524. / 51 더 많은 것을 읽으십시오 »

Food Stocks Are Falling. Don't Blame Ozempic.Packaged-food stocks are in the red as of late, and it may indicate that consumers are shifting to fresh produce, meat, deli, and bakery products.
출처: MarketWatch - 🏆 3. / 97 더 많은 것을 읽으십시오 »